PECO Q1 2026 Earnings Strong EPS Beat Amidst Market Headwinds Benitec Biopharma BNTC Q1 2026 Earnings NarrowerThanExpected Loss Highlights Operational Discipline DMAC Q1 2026 Earnings WiderthanExpected Loss as Clinical Development Costs Persist ColgatePalmolive Q1 2026 Earnings EPS Slightly Below Estimates Amid Stable Operations OXLCO Q4 2025 Earnings Mixed Results as EPS Misses Estimates Amid Stable Fund Performance ADT Q1 2026 Earnings EPS Beats Estimates by 102 as Stock Edges Lower